{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:01:55Z","timestamp":1792728115108,"version":"4.5.0"},"reference-count":90,"publisher":"The Editorial Committee of Annals of Vascular Diseases","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Vascular Diseases","Ann Vasc Dis","AVD"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3400\/avd.tasc.15-01000","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T22:01:43Z","timestamp":1445551303000},"page":"343-357","source":"Crossref","is-referenced-by-count":124,"title":["An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)"],"prefix":"10.3400","volume":"8","author":[{"given":"Michael R.","family":"Jaff","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"White","sequence":"additional","affiliation":[{"name":"The Ochsner Clinical School\u2013University of Queensland, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Hiatt","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Colorado School of Medicine, and CPC Clinical Research, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry R.","family":"Fowkes","sequence":"additional","affiliation":[{"name":"Centre for Population Health Sciences, The University of Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dormandy","sequence":"additional","affiliation":[{"name":"St George\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Razavi","sequence":"additional","affiliation":[{"name":"St Joseph Hospital, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Reekers","sequence":"additional","affiliation":[{"name":"Academic Medical Center, University Hospital, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Norgren","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine and Health, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1983","reference":[{"key":"1","unstructured":"1) Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31: S1-S296."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 Suppl S: S5-67.","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Krankenberg H, Schl\u00fcter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007; 116: 285-92.","DOI":"10.1161\/CIRCULATIONAHA.107.689141"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Saxon RR, Dake MD, Volgelzang RL, et al. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 19: 823-32.","DOI":"10.1016\/j.jvir.2008.02.008"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008; 118: 1358-65.","DOI":"10.1161\/CIRCULATIONAHA.107.735985"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Goodney PP, Beck AW, Nagle J, et al. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg 2009; 50: 54-60.","DOI":"10.1016\/j.jvs.2009.01.035"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Diehm N, Schillinger M, Minar E, et al. TASC II section E3 on the treatment of acute limb ischemia: commentary from European interventionists. J Endovasc Ther 2008; 15: 126-8.","DOI":"10.1583\/07-2255.1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Schillinger M, Diehm N, Baumgartner I, et al. TASC II section F on revascularization: commentary from an interventionist\u2019s point of view. J Endovasc Ther 2007; 14: 734-42.","DOI":"10.1177\/152660280701400519"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Indes JE, Mandawat A, Tuggle CT, et al. Endovascular procedures for aorto-iliac occlusive disease are associated with superior short-term clinical and economic outcomes compared with open surgery in the inpatient population. J Vasc Surg 2010; 52: 1173-9, 1179.e1.","DOI":"10.1016\/j.jvs.2010.05.100"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Indes JE, Pfaff MJ, Farrokhyar F, et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther 2013; 20: 443-55.","DOI":"10.1583\/13-4242.1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Leville CD, Kashyap VS, Clair DG, et al. Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. J Vasc Surg 2006; 43: 32-9.","DOI":"10.1016\/j.jvs.2005.09.034"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hans SS, DeSantis D, Siddiqui R, et al. Results of endovascular therapy and aortobifemoral grafting for Transatlantic Inter-Society type C and D aortoiliac occlusive disease. Surgery 2008; 144: 583-9; discussion 589-90.","DOI":"10.1016\/j.surg.2008.06.021"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Jongkind V, Akkersdijk GJ, Yeung KK, et al. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 2010; 52: 1376-83.","DOI":"10.1016\/j.jvs.2010.04.080"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ye W, Liu CW, Ricco JB, et al. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 2011; 53: 1728-37.","DOI":"10.1016\/j.jvs.2011.02.005"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Clair DG, Adams J, Reen B, et al. The EPIC nitinol stent system in the treatment of iliac artery lesions: one-year results from the ORION clinical trial. J Endovasc Ther 2014; 21: 213-22.","DOI":"10.1583\/13-4560.1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Mwipatayi BP, Thomas S, Wong J, et al. A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease. J Vasc Surg 2011; 54: 1561-70.","DOI":"10.1016\/j.jvs.2011.06.097"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sabri SS, Choudhri A, Orgera G, et al. Outcomes of covered kissing stent placement compared with bare metal stent placement in the treatment of atherosclerotic occlusive disease at the aortic bifurcation. J Vasc Interv Radiol 2010; 21: 995-1003.","DOI":"10.1016\/j.jvir.2010.02.032"},{"key":"18","unstructured":"18) Grimme FA, Goverde PA, Van Oostayen JA, et al. Covered stents for aortoiliac reconstruction of chronic occlusive lesions. J Cardiovasc Surg (Torino) 2012; 53: 279-89."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Humphries MD, Armstrong E, Laird J, et al. Outcomes of covered versus bare-metal balloon-expandable stents for aortoiliac occlusive disease. J Vasc Surg 2014; 60: 337-43.","DOI":"10.1016\/j.jvs.2014.02.055"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation 2012; 125: 130-9.","DOI":"10.1161\/CIRCULATIONAHA.111.075770"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol 2015; 65: 999-1009.","DOI":"10.1016\/j.jacc.2014.12.043"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lepantalo M, Laurila K, Roth WD, et al. PTFE bypass or thrupass for superficial femoral artery occlusion? A randomised controlled trial. Eur J Vasc Endovasc Surg 2009; 37: 578-84.","DOI":"10.1016\/j.ejvs.2009.01.003"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-34.","DOI":"10.1016\/S0140-6736(05)67704-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010; 51: 5S-17S.","DOI":"10.1016\/j.jvs.2010.01.073"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received. J Vasc Surg 2010; 51: 18S-31S.","DOI":"10.1016\/j.jvs.2010.01.074"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008; 358: 689-99.","DOI":"10.1056\/NEJMoa0706356"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Faglia E, Clerici G, Airoldi F, et al. Revascularization by angioplasty of type D femoropopliteal and long infrapopliteal lesion in diabetic patients with critical limb ischemia: are TASC II recommendations suitable? A population-based cohort study. Int J Low Extrem Wounds 2012; 11: 277-85.","DOI":"10.1177\/1534734612463701"},{"key":"28","unstructured":"28) Gargiulo M, Giovanetti F, Bianchini Massoni C, et al. Bypass to the ankle and foot in the era of endovascular therapy of tibial disease. Results and factors influencing the outcome. J Cardiovasc Surg (Torino) 2014; 55: 367-74."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Conte MS, Bandyk DF, Clowes AW, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006; 43: 742-51; discussion 751.","DOI":"10.1016\/j.jvs.2005.12.058"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Lensvelt MM, Holewijn S, Fritschy WM, et al. SUrgical versus PERcutaneous Bypass: SUPERB-trial; Heparin-bonded endoluminal versus surgical femoro-popliteal bypass: study protocol for a randomized controlled trial. Trials 2011; 12: 178.","DOI":"10.1186\/1745-6215-12-178"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Jones WS, Dolor RJ, Hasselblad V, et al. Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia. Am Heart J 2014; 167: 489-98.e7.","DOI":"10.1016\/j.ahj.2013.12.012"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Twine CP, McLain AD. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev 2010: CD001487.","DOI":"10.1002\/14651858.CD001487.pub2"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Pereira CE, Albers M, Romiti M, et al. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg 2006; 44: 510-7.","DOI":"10.1016\/j.jvs.2006.04.054"},{"key":"34","unstructured":"34) Norgren L, Troeng T. Personal communication on behalf of the Swedish Vascular Registry (SWEDVASC). 2010."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Geraghty PJ, Mewissen MW, Jaff MR, et al. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 2013; 58: 386-95.e4.","DOI":"10.1016\/j.jvs.2013.01.050"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Saxon RR, Chervu A, Jones PA, et al. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol 2013; 24: 165-73.","DOI":"10.1016\/j.jvir.2012.10.004"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010; 3: 267-76.","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 2012; 19: 1-9.","DOI":"10.1583\/11-3627.1"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Bown MJ, Bolia A, Sutton AJ. Subintimal angioplasty: meta-analytical evidence of clinical utility. Eur J Vasc Endovasc Surg 2009; 38: 323-37.","DOI":"10.1016\/j.ejvs.2009.05.014"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-88.","DOI":"10.1056\/NEJMoa051303"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Brescia AA, Wickers BM, Correa JC, et al. Stenting of femoropopliteal lesions using interwoven nitinol stents. J Vasc Surg 2015; 61: 1472-8.","DOI":"10.1016\/j.jvs.2015.01.030"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Das T, Mustapha J, Indes J, et al. Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: the CONFIRM series, a prospective multicenter registry. Catheter Cardiovasc Interv 2014; 83: 115-22.","DOI":"10.1002\/ccd.25046"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Dave RM, Patlola R, Kollmeyer K, et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther 2009; 16: 665-75.","DOI":"10.1583\/09-2781.1"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Korabathina R, Mody KP, Yu J, et al. Orbital atherectomy for symptomatic lower extremity disease. Catheter Cardiovasc Interv 2010; 76: 326-32.","DOI":"10.1002\/ccd.22508"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Laird JR, Zeller T, Gray BH, et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther 2006; 13: 1-11.","DOI":"10.1583\/05-1674.1"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Zeller T, Krankenberg H, Steinkamp H, et al. One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther 2009; 16: 653-62.","DOI":"10.1583\/09-2826.1"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Zeller T, Rastan A, Sixt S, et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 2006; 48: 1573-8.","DOI":"10.1016\/j.jacc.2006.07.031"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) McKinsey JF, Zeller T, Rocha-Singh KJ, et al. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv 2014; 7: 923-33.","DOI":"10.1016\/j.jcin.2014.05.006"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Dake MD, Ansel GM, Jaff MR, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol 2013; 61: 2417-27.","DOI":"10.1016\/j.jacc.2013.03.034"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Scheinert D, Duda S, Zeller T, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv 2014; 7: 10-9.","DOI":"10.1016\/j.jcin.2013.05.022"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Tepe G, Laird J, Schneider P, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 2015; 131: 495-502.","DOI":"10.1161\/CIRCULATIONAHA.114.011004"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Antoniou GA, Chalmers N, Georgiadis GS, et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 2013; 57: 242-53.","DOI":"10.1016\/j.jvs.2012.07.038"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608-21.","DOI":"10.1056\/NEJM200105243442108"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Albers M, Romiti M, Brochado-Neto FC, et al. Meta-analysis of alternate autologous vein bypass grafts to infrapopliteal arteries. J Vasc Surg 2005; 42: 449-55.","DOI":"10.1016\/j.jvs.2005.05.031"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Albers M, Romiti M, Pereira CA, et al. Meta-analysis of allograft bypass grafting to infrapopliteal arteries. Eur J Vasc Endovasc Surg 2004; 28: 462-72.","DOI":"10.1016\/j.ejvs.2004.08.009"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Dorweiler B, Neufang A, Schmiedt W, et al. Pedal arterial bypass for limb salvage in patients with diabetes mellitus. Eur J Vasc Endovasc Surg 2002; 24: 309-13.","DOI":"10.1053\/ejvs.2002.1735"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Kashyap VS, Ahn SS, Quinones-Baldrich WJ, et al. Infrapopliteal-lower extremity revascularization with prosthetic conduit: a 20-year experience. Vasc Endovascular Surg 2002; 36: 255-62.","DOI":"10.1177\/153857440203600402"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Schanzer A, Hevelone N, Owens CD, et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 2007; 46: 1180-90; discussion 1190.","DOI":"10.1016\/j.jvs.2007.08.033"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Conte MS, Geraghty PJ, Bradbury AW, et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009; 50: 1462-73.e1-3.","DOI":"10.1016\/j.jvs.2009.09.044"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Iida O, Nakamura M, Yamauchi Y, et al. Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up. Circ Cardiovasc Interv 2013; 6: 68-76.","DOI":"10.1161\/CIRCINTERVENTIONS.112.975318"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Iyer SS, Dorros G, Zaitoun R, et al. Retrograde recanalization of an occluded posterior tibial artery by using a posterior tibial cutdown: two case reports. Cathet Cardiovasc Diagn 1990; 20: 251-3.","DOI":"10.1002\/ccd.1810200408"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Romiti M, Albers M, Brochado-Neto FC, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008; 47: 975-81.","DOI":"10.1016\/j.jvs.2008.01.005"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Ansel GM, Sample NS, Botti III CF, et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv 2004; 61: 1-4.","DOI":"10.1002\/ccd.10731"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Das T, McNamara T, Gray B, et al. Cryoplasty therapy for limb salvage in patients with critical limb ischemia. J Endovasc Ther 2007; 14: 753-62.","DOI":"10.1583\/07-2147.1"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Zeller T, Rastan A, Schwarzw\u00e4lder U, et al. Midterm results after atherectomy-assisted angioplasty of below-knee arteries with use of the Silverhawk device. J Vasc Interv Radiol 2004; 15: 1391-7.","DOI":"10.1097\/01.RVI.0000138060.05915.9D"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) White CJ. Brave new world: value-based purchasing for peripheral vascular stents is coming to a hospital near you. Circulation 2013; 127: 2475-6.","DOI":"10.1161\/CIRCULATIONAHA.113.003491"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Antoniou GA, Chalmers N, Kanesalingham K, et al. Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents. J Endovasc Ther 2013; 20: 131-44.","DOI":"10.1583\/1545-1550-20.2.131"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 2012; 55: 390-8.","DOI":"10.1016\/j.jvs.2011.07.099"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Fusaro M, Cassese S, Ndrepepa G, et al. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials. JACC Cardiovasc Interv 2013; 6: 1284-93.","DOI":"10.1016\/j.jcin.2013.08.007"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Katsanos K, Spiliopoulos S, Diamantopoulos A, et al. Systematic review of infrapopliteal drug-eluting stents: a meta-analysis of randomized controlled trials. Cardiovasc Intervent Radiol 2013; 36: 645-58.","DOI":"10.1007\/s00270-013-0578-2"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Rastan A, Brechtel K, Krankenberg H, et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol 2012; 60: 587-91.","DOI":"10.1016\/j.jacc.2012.04.035"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Rastan A, Tepe G, Krankenberg H, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multicentre, randomized clinical trial. Eur Heart J 2011; 32: 2274-81.","DOI":"10.1093\/eurheartj\/ehr144"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Scheinert D, Katsanos K, Zeller T, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol 2012; 60: 2290-5.","DOI":"10.1016\/j.jacc.2012.08.989"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Yang X, Lu X, Ye K, et al. Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease. Vasc Endovascular Surg 2014; 48: 18-26.","DOI":"10.1177\/1538574413510626"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Siablis D, Kitrou PM, Spiliopoulos S, et al. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial. JACC Cardiovasc Interv 2014; 7: 1048-56.","DOI":"10.1016\/j.jcin.2014.04.015"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Rand T, Lammer J, Rabbia C, et al. Percutaneous transluminal angioplasty versus turbostatic carbon-coated stents in infrapopliteal arteries: InPeria II trial. Radiology 2011; 261: 634-42.","DOI":"10.1148\/radiol.11101357"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Randon C, Jacobs B, De Ryck F, et al. Angioplasty or primary stenting for infrapopliteal lesions: results of a prospective randomized trial. Cardiovasc Intervent Radiol 2010; 33: 260-9.","DOI":"10.1007\/s00270-009-9765-6"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Feiring AJ, Krahn M, Nelson L, et al. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol 2010; 55: 1580-9.","DOI":"10.1016\/j.jacc.2009.11.072"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 2009; 20: 1141-50.","DOI":"10.1016\/j.jvir.2009.05.031"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 2011; 58: 1105-9.","DOI":"10.1016\/j.jacc.2011.05.034"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Fanelli F, Cannavale A, Boatta E, et al. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther 2012; 19: 571-80.","DOI":"10.1583\/JEVT-12-3926MR.1"},{"key":"82","unstructured":"82) Fanelli F, Cannavale A, Corona M, et al. The \u201cDEBELLUM\u201d \u2014 lower limb multilevel treatment with drug eluting balloon \u2014 randomized trial: 1-year results. J Cardiovasc Surg (Torino) 2014; 55: 207-16."},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Liistro F, Porto I, Angioli P, et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 2013; 128: 615-21.","DOI":"10.1161\/CIRCULATIONAHA.113.001811"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Zeller T, Baumgartner I, Scheinert D, et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 2014; 64: 1568-76.","DOI":"10.1016\/j.jacc.2014.06.1198"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Farber A, Rosenfield K, Menard M. The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia. Tech Vasc Interv Radiol 2014; 17: 221-4.","DOI":"10.1053\/j.tvir.2014.08.012"},{"key":"86","unstructured":"86) University of Birmingham Clinical Trials Unit. BASIL-2 trial. http:\/\/www.birmingham.ac.uk\/research\/activity\/mds\/trials\/bctu\/trials\/portfolio-v\/Basil-2\/index.aspx. Accessed May 31, 2015."},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Chang RW, Goodney PP, Baek JH, et al. Long-term results of combined common femoral endarterectomy and iliac stenting\/stent grafting for occlusive disease. J Vasc Surg 2008; 48: 362-7.","DOI":"10.1016\/j.jvs.2008.03.042"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Timaran CH, Stevens SL, Freeman MB, et al. Infrainguinal arterial reconstructions in patients with aortoiliac occlusive disease: the influence of iliac stenting. J Vasc Surg 2001; 34: 971-8.","DOI":"10.1067\/mva.2001.119400"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Creager MA, Goldstone J, Hirshfeld JW, et al. ACC\/ACP\/SCAI\/SVMB\/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology\/American Heart Association\/American College of Physician Task Force on Clinical Competence (ACC\/ACP\/SCAI\/SVMB\/SVS Writing Committee to develop a clinical competence statement on peripheral vascular disease). J Am Coll Cardiol 2004; 44: 941-57.","DOI":"10.1016\/j.jacc.2003.10.012"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014; 59: 220-34.e1-2.","DOI":"10.1016\/j.jvs.2013.08.003"}],"container-title":["Annals of Vascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/avd\/8\/4\/8_tasc.15-01000\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T20:27:56Z","timestamp":1567283276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/avd\/8\/4\/8_tasc.15-01000\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3400\/avd.tasc.15-01000","relation":{},"ISSN":["1881-641X","1881-6428"],"issn-type":[{"value":"1881-641X","type":"print"},{"value":"1881-6428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}